Chris is a seasoned pharmaceutical executive bringing more than 20 years of pharmaceutical operations and business development expertise to Jupiter Capital Management. Drawing from transactional experiences spanning the breadth of life science verticals, Chris' primary coverage and focus spans the medical device, digital health, and life sciences services segments.
Chris has advised dozens of senior management teams on a variety of complex strategic business development & licensing issues, ranging from transaction process considerations to valuation and transaction structure, value proposition communication and buyer/seller analysis, along with the plethora of managerial challenges faced in executing complex corporate transactions.
Chris' focus is servicing pharmaceutical industry clients and leading transformation transactions including, but not limited to, funding/financing efforts, drug development plans, commercialization strategies, asset in-licensing and/or out-licensing, expansion of development pipelines, mergers & acquisitions, joint venture transactions, and leading all partnering and licensing efforts within the pharmaceutical healthcare segment.
Prior to joining Jupiter Capital Management, Chris was the Chief Operating Officer and VP of Business Development at TFF Pharmaceuticals.
Based in Princeton, New Jersey, Chris holds a Bachelor’s degree in finance from Villanova University and a Master’s degree in business management from Rider University.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.